Cargando…
Efficacy and safety of ursodeoxycholic acid in children with cholestasis: A systematic review and meta-analysis
OBJECTIVES: Ursodeoxycholic acid (UDCA) is the main therapeutic drug for cholestasis, but its use in children is controversial. We conducted this study to evaluate the efficacy and safety of ursodeoxycholic acid in children with cholestasis. METHODS: We searched Medline (Ovid), Embase (Ovid), Cochra...
Autores principales: | Huang, Liang, Li, Siyu, Chen, Jingjing, Zhu, Yu, Lan, Ke, Zeng, Linan, Jiang, Xuehua, Zhang, Lingli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9888709/ https://www.ncbi.nlm.nih.gov/pubmed/36719881 http://dx.doi.org/10.1371/journal.pone.0280691 |
Ejemplares similares
-
Ursodeoxycholic Acid and S-adenosylmethionine for the Treatment of Intrahepatic Cholestasis of Pregnancy: A Meta-analysis
por: Zhang, Yang, et al.
Publicado: (2016) -
Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis
por: Ovadia, Caroline, et al.
Publicado: (2021) -
Ursodeoxycholic acid versus phenobarbital for cholestasis in the Neonatal Intensive Care Unit
por: Lewis, Tamorah, et al.
Publicado: (2018) -
The effects of ursodeoxycholic acid on sepsis-induced cholestasis management in an animal model
por: Ainosah, Randa H., et al.
Publicado: (2020) -
Ursodeoxycholic Acid and SMOFlipid for Treating Parenteral Nutrition Associated Cholestasis in Infants
por: Al-Alaiyan, Saleh, et al.
Publicado: (2022)